Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · CLEDUCATE

CLEDUCATE

Consumer DiscretionaryOther Consumer Services₹279 cr market cap
₹52.95 ▲ +2.34% today As of 19 Nov 2026
52-week low ₹38.0652-week high ₹90.71

-43.0% from the 52-week high · +35.9% above the low

CL Educate Ltd. is a holding company, which engages in the provision of education products, services, content, and infrastructure across education value chain. The company is headquartered in New Delhi, Delhi and currently employs 354 full-time employees. The company went IPO on 2017-03-31. The Company’s segments include EdTech and MarTech. Under the EdTech segment it serves various products which can be categorized into: Test Preparation, Platform Monetization and Content Monetization. For the MarTech segment, under the brand name Kestone, the Company offers services to corporates: Experiential Marketing & Event Management Solutions, Digital & MarComm services, Customized Engagement Programs, Transitioning Businesses into the Metaverse and Strategic Business Solutions. Its Platform Monetization offers various educational institutions an array of its products, such as Integrated solutions to educational institutions & universities across India, Student Recruitment Services and Research & Incubation Services. Its test preparation provides Career Launcher offers various products through its digital and business partner channels of distribution.

The short version. CLEDUCATE reported revenue of ₹170 crore for Sep 2026, up 3.7% from a year earlier. Net profit was ₹8 crore (up 60.0% year on year). Return on equity was -10.2% in Mar 2026. Promoter holding was 51.72% in Sep 2026, down 1.42 points over 8 quarters.

1 · The price

How has the stock traded?

CLEDUCATE trades 43.0% below its 52-week high and 35.9% above its 52-week low.

Change over period: —

1M-1.9%
3M-14.2%
6M+17.8%
1Y-38.2%

2 · The business

Is it growing?

Sales, year on year+3.7%

Sep 2026 revenue of ₹170 cr.

Profit, year on year+60.0%

Sep 2026 net profit of ₹8 cr.

Net margin4.9%

1.7 pts higher than a year earlier.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue1701281181201641469771
Net profit8-2-10-175-4-16-3
Net margin %4.9-1.2-8.7-14.03.2-2.6-16.8-3.7
EPS (₹)1.55-0.28-1.9-3.120.96-0.71-3.03-0.49

Annual

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue548358319291207184309339
Net profit-26-11152314-12-5320
Net margin %-4.7-3.14.77.76.6-6.3-17.25.9
EPS (₹)-4.77-2.082.794.092.43-2.06-9.383.52

3 · The quality

How well does it turn capital into profit?

Return on equity was -10.2% in Mar 2026; debt to equity is 0.92.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %-10.2-4.15.48.2
Return on capital %4.81.28.67.2
EBITDA margin %11.37.711.810.7
Net margin %-4.5-3.04.57.6

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR24.1%24.0%
Profit CAGR—17.2%
Debt to equity0.92
Interest cover0.5x
Current ratio1.08

4 · The owners

Who holds it, and are they adding?

Promoter holding51.72%

Down 1.42 pts over 8 quarters.

Foreign institutions7.79%

Down 0.41 pts over 8 quarters.

Mutual fund schemes0

+0 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter53.1453.1653.1651.7851.7851.7851.7851.72-1.42
FII8.28.127.987.997.877.897.87.79-0.41
DII00.020000000
Public38.6638.738.8640.2340.3540.3240.4140.49+1.83

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for CLEDUCATE are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about CLEDUCATE

What is the CLEDUCATE share price?

CLEDUCATE (CLEDUCATE) last closed at ₹52.95, up 2.34% on the day. Its 52-week range is ₹38.06 to ₹90.71.

What is the market cap of CLEDUCATE?

CLEDUCATE has a market capitalisation of about ₹279 crore.

How are CLEDUCATE's latest results?

CLEDUCATE reported revenue of ₹170 crore for Sep 2026, up 3.7% from a year earlier. Net profit was ₹8 crore (up 60.0% year on year). Return on equity was -10.2% in Mar 2026. Promoter holding was 51.72% in Sep 2026, down 1.42 points over 8 quarters.

Who owns CLEDUCATE?

As of Sep 2026, shareholding was: Promoter 51.72%, FII 7.79%, Public 40.49%.

How many mutual funds hold CLEDUCATE?

0 mutual fund schemes held CLEDUCATE in October 2026. That compares with 0 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 16 Dec 2022 · Bonus issue 1:1
  • 30 Sep 2021 · Stock Split From Rs.10/- to Rs.5/-
  • 22 Nov 2019 · Interim Dividend - Rs. 1
  • 14 Aug 2018 · Interim Dividend - Rs. 1

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.